Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Mimecan Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA548255

Catalog No. PA548255


Add to cart

Description

Description

Predicted to react with bovine based on sequence homology.

Mimecan induces ectopic bone formation in conjunction with transforming growth factor beta. Mimecan is a small proteoglycan which contains tandem leucine-rich repeats. Mimecan is encoded by the OGN gene, a member of the small leucine-rich proteoglycan (SLRP) family of proteins. Mimecan induces ectopic bone formation in conjunction with transforming growth factor beta (TGF-beta-1 or TGF-beta-2) and may regulate osteoblast differentiation. High expression of mimecan protein may be associated with elevated heart left ventricular mass. Alternative splicing results in multiple transcript variants of mimecan. Alternatively spliced transcript variants that encode mimecan have been found.
Specifications

Specifications

Mimecan
Polyclonal
PBS with 0.09% sodium azide
P20774
Mimecan, Osteoglycin, Osteoinductive factor, OIF, OGN, OIF, SLRR3A
Rabbit
IgG
400 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
4969
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot
Unconjugated
OGN
Liquid
OGN
KLH conjugated synthetic peptide between 246-276 amino acids from the C-terminal region of human OGN.
Ammonium sulfate precipitation
RUO
Antibody
Polyclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit